Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 38Gastrointestinal 34Head & Neck 10Thoracic 9Gynecologic 9Tumor-Agnostic 8Other hematologic neoplasm 8Genitourinary 6Lymphoid 5Endocrine 3Sarcoma 2CNS 2Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other 1NET 1Classical hematology 1

Conditions

Osteolysis 1Multiple Myeloma 1Motor Activity 1

Interventions

Dexamethasone 478Lenalidomide 297Cyclophosphamide 271Bortezomib 266Melphalan 211Calcium Dobesilate 189fludarabine phosphate 121daratumumab 121Peripheral Blood Stem Cell Transplantation 101fludarabine 99carfilzomib 98Thalidomide 94pomalidomide 92Filgrastim 92Whole-Body Irradiation 88Mycophenolic Acid 88Busulfan 80Tacrolimus 75Granulocyte Colony-Stimulating Factor 72dexamethasone acetate 65ixazomib 62Cyclosporine 59dexamethasone 21-phosphate 56Antilymphocyte Serum 51auricularum 50isatuximab 43Radiotherapy 41Etoposide 40Stem Cell Transplantation 39Methotrexate 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Control Groups × Plasma cell × Clear all
NCT07026799 2025-06-18

GMMG-HD8-INDEX

University Hospital Heidelberg

Phase NA Active not recruiting
50 enrolled
Plasma cell

Motor Activity, Multiple Myeloma, Osteolysis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡